One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study

Introduction: The impact of ETI therapy on pulmonary function and nutritional status has been widely studied; the literature on the possible outcomes on glycemic control and insulin requirement in patients affected by CFRD is controversial. Aim: The main objective of our study was to evaluate HbA1c...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Marta Bassi, Marina Francesca Strati, Gaia Spiandorello, Marta Scalas, Federico Cresta, Maria Grazia Calevo, Giuseppe d’Annunzio, Carlo Castellani, Nicola Minuto, Mohamad Maghnie, Rosaria Casciaro
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2024-10-01
Edice:	Life
Témata:	CFRD cystic fibrosis diabetes CFTR modulators ETI treatment
On-line přístup:	https://www.mdpi.com/2075-1729/14/10/1309
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!